The Bioterrorism Act

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-01-02-2004
Volume 28
Issue 1

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Related Content